__timestamp | Arrowhead Pharmaceuticals, Inc. | Gilead Sciences, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 175000 | 24890000000 |
Thursday, January 1, 2015 | 382000 | 32639000000 |
Friday, January 1, 2016 | 158333 | 30390000000 |
Sunday, January 1, 2017 | 31407709 | 26107000000 |
Monday, January 1, 2018 | 16142321 | 22127000000 |
Tuesday, January 1, 2019 | 168795577 | 22449000000 |
Wednesday, January 1, 2020 | 87992066 | 24689000000 |
Friday, January 1, 2021 | 138287000 | 27305000000 |
Saturday, January 1, 2022 | 243231000 | 27281000000 |
Sunday, January 1, 2023 | 240735000 | 27116000000 |
Monday, January 1, 2024 | 3551000 | 28754000000 |
Data in motion
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and innovation. Over the past decade, Gilead Sciences, Inc. and Arrowhead Pharmaceuticals, Inc. have showcased contrasting trajectories in their annual revenue growth.
Gilead Sciences, a giant in the biotech industry, has consistently maintained a robust revenue stream, peaking in 2015 with a staggering $32.6 billion. Despite a slight decline in subsequent years, Gilead's revenue remained strong, averaging around $27 billion annually from 2016 to 2023.
In contrast, Arrowhead Pharmaceuticals, a smaller player, has demonstrated impressive growth, albeit from a lower base. From a modest $175,000 in 2014, Arrowhead's revenue surged to over $240 million by 2023, marking a phenomenal growth rate of over 137,000%.
This comparison highlights the diverse strategies and market positions of these two companies, offering valuable insights into the biotech sector's evolving landscape.
Breaking Down Revenue Trends: Gilead Sciences, Inc. vs Vertex Pharmaceuticals Incorporated
Gilead Sciences, Inc. vs Ascendis Pharma A/S: Annual Revenue Growth Compared
Breaking Down Revenue Trends: Gilead Sciences, Inc. vs Grifols, S.A.
Breaking Down Revenue Trends: Gilead Sciences, Inc. vs TG Therapeutics, Inc.
Gilead Sciences, Inc. vs Amneal Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Revenue Insights: Gilead Sciences, Inc. and Supernus Pharmaceuticals, Inc. Performance Compared
Who Generates More Revenue? Gilead Sciences, Inc. or Travere Therapeutics, Inc.
Breaking Down Revenue Trends: BioMarin Pharmaceutical Inc. vs Arrowhead Pharmaceuticals, Inc.
Cytokinetics, Incorporated and Arrowhead Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Who Generates More Revenue? ACADIA Pharmaceuticals Inc. or Arrowhead Pharmaceuticals, Inc.
Annual Revenue Comparison: Arrowhead Pharmaceuticals, Inc. vs Mesoblast Limited
Annual Revenue Comparison: Arrowhead Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.